Gene · 4882
Papers1,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,917
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Large B-cell lymphoma with IRF4 rearrangement: six case reports and a literature review]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 35968590 | PubTator, text mining | PubMed |
| Novel Insights Into the Genetic Causes of Short Stature in Children. | touchREV Endocrinol | 2022 | 35949366 | PubTator, text mining | PubMed |
| Clonal germinal center B cells function as a niche for T-cell lymphoma. | Blood | 2022 | 35921527 | PubTator, text mining | PubMed |
| Inhibition of acylglycerol kinase sensitizes DLBCL to venetoclax via upregulation of FOXO1-mediated BCL-2 expression. | Theranostics | 2022 | 35910796 | PubTator, text mining | PubMed |
| Regulation of oocyte maturation: Role of conserved ERK signaling. | Mol Reprod Dev | 2022 | 35908193 | PubTator, text mining | PubMed |
| Metabolism reprogramming signature associated with stromal cells abundance in tumor microenvironment improve prognostic risk classification for gastric cancer. | BMC Gastroenterol | 2022 | 35907819 | PubTator, text mining | PubMed |
| Distinct Chemokine Receptor Expression Profiles in De Novo DLBCL, Transformed Follicular Lymphoma, Richter's Trans-Formed DLBCL and Germinal Center B-Cells. | Int J Mol Sci | 2022 | 35887224 | PubTator, text mining | PubMed |
| Neuroimaging analyses from a randomized, controlled study to evaluate plasma exchange with albumin replacement in mild-to-moderate Alzheimer's disease: additional results from the AMBAR study. | Eur J Nucl Med Mol Imaging | 2022 | 35867135 | PubTator, text mining | PubMed |
| CDC50 Orthologues in Plasmodium falciparum Have Distinct Roles in Merozoite Egress and Trophozoite Maturation. | mBio | 2022 | 35862778 | PubTator, text mining | PubMed |
| A long-acting C-natriuretic peptide for achondroplasia. | Proc Natl Acad Sci U S A | 2022 | 35858423 | PubTator, text mining | PubMed |
| NR1H3 (LXRα) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphoma. | Hematol Oncol | 2022 | 35850118 | PubTator, text mining | PubMed |
| Receptor Guanylyl Cyclase C and Cyclic GMP in Health and Disease: Perspectives and Therapeutic Opportunities. | Front Endocrinol (Lausanne) | 2022 | 35846281 | PubTator, text mining | PubMed |
| An Autophagy-Related Gene Signature can Better Predict Prognosis and Resistance in Diffuse Large B-Cell Lymphoma. | Front Genet | 2022 | 35846146 | PubTator, text mining | PubMed |
| Phase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma. | EJHaem | 2022 | 35846031 | PubTator, text mining | PubMed |
| Purification, characterization, and preliminary serial crystallography diffraction advances structure determination of full-length human particulate guanylyl cyclase A receptor. | Sci Rep | 2022 | 35821229 | PubTator, text mining | PubMed |
| Transplant Onconephrology in Patients With Kidney Transplants. | Adv Chronic Kidney Dis | 2022 | 35817526 | PubTator, text mining | PubMed |
| Updated List of Transport Proteins in Plasmodium falciparum. | Front Cell Infect Microbiol | 2022 | 35811673 | PubTator, text mining | PubMed |
| Genetic Aspects of Small for Gestational Age Infants Using Targeted-Exome Sequencing and Whole-Exome Sequencing: A Single Center Study. | J Clin Med | 2022 | 35806993 | PubTator, text mining | PubMed |
| Super-enhancer hypermutation alters oncogene expression in B cell lymphoma. | Nature | 2022 | 35794478 | PubTator, text mining | PubMed |
| Alterations of Cardiac Protein Kinases in Cyclic Nucleotide-Dependent Signaling Pathways in Human Ischemic Heart Failure. | Front Cardiovasc Med | 2022 | 35783854 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4882/papers?page=17